Look for Drugs and Conditions

Roflumilast

Roflumilast

Roflumilast is PDE4 inhibitor used for chronic obstructive pulmonary disease.

Indications

To reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.


Dosage

Oral; 500mcg per day.


Contra-Indications

Moderate to severe liver impairement.


Special Precautions

Paediatric: Safety and efficacy not established in paediatric group. Pregnancy: Category C. Lactation: Not to be used by lactating mother. Elderly: Use with caution.


Side Effects

Diarrhea, Weight loss, Nausea, Headache, Insomnia, Decreased appetite, Abdominal pain, Rhinitis, Sinusitis, Urinary tract infection, Depression.


Drug Interactions

Rifampicin, phenobarbital, carbamazepine, erythromycin, ketoconazole, fluvoxamine, enoxacin, cimetidine, oral contraceptives.


Ad 5